Hong Kong, long renowned as one of the world's most prosperous financial centers, has now added another title - &nb

Cell line development is a cornerstone in the development of macromolecule drugs. Traditional methods involve transfec

AlfaDAX丨The Prediction Accuracy of Aggregation and Precipitation of 28 Innovative Molecules Reached 89.3% AlfaD

Recently, Great Bay Bio’s wholly-owned subsidiary (Shenzhen Taili Biotechnology) has been assessed and certified as me

The online system of Bio-product Molecule Assessment and Optimization Platform Platform (#AlfaDAX) was launched. The A

Hong Kong May 16, 2024 Great Bay Bio (hereinafter referred to as “GBB”), Pebble Accelerator (a subsidiary of

龙腾盛世，万物争春。2月24日（元宵佳节），大湾生物隆重举办2024年战略发布会暨开工仪式，全体同仁齐聚一堂，共赴新征程。 2024年战略发布会 本年度战略发布会以“钢铁计划”为主题，旨在打造技术铁军

Organized by Deloitte, the 2023 "Deloitte Rising Star" selection event, after nearly half a year of evaluation and review, recently held a grand award ceremony. Great Bay Bio was awarded the "2023 Deloitte Rising Star Award". 大湾生物董事长兼联合创始人梁国龙先生